KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Total Debt (2016 - 2024)

Exact Sciences (EXAS) has disclosed Total Debt for 15 consecutive years, with $50.0 million as the latest value for Q1 2024.

  • Quarterly Total Debt changed 0.0% to $50.0 million in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $50.0 million through Mar 2024, changed 0.0% year-over-year, with the annual reading at $50.0 million for FY2023, 0.0% changed from the prior year.
  • Total Debt for Q1 2024 was $50.0 million at Exact Sciences, roughly flat from $50.0 million in the prior quarter.
  • The five-year high for Total Debt was $50.0 million in Q2 2022, with the low at $21.4 million in Q3 2021.
  • Average Total Debt over 5 years is $38.1 million, with a median of $50.0 million recorded in 2022.
  • The sharpest move saw Total Debt tumbled 93.17% in 2020, then skyrocketed 133.23% in 2022.
  • Over 5 years, Total Debt stood at $22.3 million in 2020, then decreased by 4.05% to $21.4 million in 2021, then surged by 133.23% to $50.0 million in 2022, then changed by 0.0% to $50.0 million in 2023, then changed by 0.0% to $50.0 million in 2024.
  • According to Business Quant data, Total Debt over the past three periods came in at $50.0 million, $50.0 million, and $50.0 million for Q1 2024, Q4 2023, and Q3 2023 respectively.